Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- Cantor Fitzgerald
- Truist Securities
- HC Wainwright & Co.
- Wells Fargo
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Affimed
What is the target price for Affimed (AFMD)?
The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Affimed (AFMD)?
The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.
When is the next analyst rating going to be posted or updated for Affimed (AFMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.
Is the Analyst Rating Affimed (AFMD) correct?
While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.